May 24, 2025Applied Health Economics and Health PolicyOpen Access

Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease

View Full Paper

Ask AI

Bookmark

Why the study?

The cost-effectiveness of different cholesterol treatment escalation thresholds in patients with established CVD taking a statin remains uncertain.

What is the most cost-effective LDL-C threshold for escalating lipid therapy in patients with established CVD on a statin?

Structured PICO

What is the most cost-effective LDL-C threshold for escalating lipid therapy in patients with established CVD on a statin?

Population

590,917 adult individuals with established cardiovascular disease (CVD) taking a statin in primary care, 61.7% men, based in England.

Intervention

Lipid therapy escalation (e.g., ezetimibe, inclisiran) at various LDL-C treatment escalation thresholds (0-4.0 mmol/L).

Comparator

Different LDL-C treatment escalation thresholds compared against each other.

Outcome

Lifetime costs and quality-adjusted life years (QALYs) to determine cost-effectiveness.

An LDL-C threshold of 2.0 mmol/L for escalating lipid therapy is cost-effective for secondary prevention of CVD, supporting updated NICE guidelines.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports modeled LDL-C escalation thresholds (~2.0–2.2 mmol/L) in statin-treated CVD; leaves open randomized confirmation of real-world cost-effectiveness.

Cite This Study

Mariani et al. (2025) studied this question.

synapsesocial.com/papers/6a853f770940f46f59d9846f https://doi.org/10.1007/s40258-025-00977-6

Topics

Statin therapy Women and heart disease Cardiovascular prevention

View Full Paper

Ask AI

Bookmark

Implication

Supports modeled LDL-C escalation thresholds (~2.0–2.2 mmol/L) in statin-treated CVD; leaves open randomized confirmation of real-world cost-effectiveness.

Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease

Structured PICO

Discussion

Implication

Cite This Study

Topics

Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider